Shots:
The US FDA has approved the Selution SLR (Sustained Limus Release) Drug-Eluting Balloon (DEB) for the treatment of coronary in-stent restenosis (ISR)
Approval was supported by data from the SELUTION4ISR trial assessing Selution SLR DEB vs SoC, incl. 80% drug-eluting stents, in pts (n >400) with coronary ISR across the US, Canada, Brazil, &…
